ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 82 filers reported holding ENZO BIOCHEM INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,000 | 0.0% | 329 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | 0.0% | 329 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | +100.0% | 329 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 329 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | -99.9% | 329 | -99.9% | 0.00% | -100.0% |
| Q3 2015 | $1,176,000 | -42.5% | 370,939 | -45.0% | 0.00% | -50.0% |
| Q2 2015 | $2,044,000 | -3.9% | 674,751 | -6.4% | 0.00% | 0.0% |
| Q1 2015 | $2,127,000 | -49.3% | 720,982 | -23.6% | 0.00% | -50.0% |
| Q4 2014 | $4,192,000 | -23.2% | 944,043 | -10.9% | 0.00% | -33.3% |
| Q3 2014 | $5,456,000 | -5.9% | 1,059,321 | -4.1% | 0.01% | -14.3% |
| Q2 2014 | $5,800,000 | +21.8% | 1,104,843 | -3.5% | 0.01% | +16.7% |
| Q1 2014 | $4,762,000 | +39.4% | 1,144,747 | -2.1% | 0.01% | +50.0% |
| Q4 2013 | $3,415,000 | +12.5% | 1,169,562 | -2.9% | 0.00% | 0.0% |
| Q3 2013 | $3,035,000 | +13.8% | 1,204,540 | -6.0% | 0.00% | 0.0% |
| Q2 2013 | $2,667,000 | – | 1,282,042 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
| VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
| AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
| Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
| Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
| Corsair Capital Management | 58,657 | $188,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |